PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5682.20%
Net income growth above 1.5x CRN.AX's 47.33%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
56.16%
Some D&A expansion while CRN.AX is negative at -26.77%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.81%
Negative yoy while CRN.AX is 384.41%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
42.92%
Operating cash flow growth below 50% of CRN.AX's 16496.02%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-64.59%
Negative yoy CapEx while CRN.AX is 58.16%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.07%
Both yoy lines negative, with CRN.AX at -37.14%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-515.09%
We reduce yoy invests while CRN.AX stands at 67.40%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.